Arrythmia Monitoring Devices Market is expected to reach US$ 9,742.95 million With CAGR of 6.6% from 2021 to 2028 | Abbott, Koninklijke Philips N.V., General Electric Company, Hill-Rom Holding Inc., Medtronic, Biotronik, Inc., AliveCor, Inc, ACS Diagnosti

According to our latest study on “Arrythmia Monitoring Devices Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Application, and End User,” the market is projected to reach US$ 9,742.95 million by 2028 from US$ 6,212.59 million in 2021; it is expected to grow at a CAGR of 6.6% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments in the market. The growth of the arrythmia monitoring devices market is primarily attributed to increase in cardiovascular disease incidence, and surge in geriatric population. However, the high cost of products and procedures hinders the market growth.

Request for sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00004202/?openpr-10225

Based on type, the arrythmia monitoring devices market is segmented into ECG monitors, implantable monitors, Holter monitors, mobile cardiac telemetry, and others. The Holter monitors segment held the largest share of the market in 2020. Holter monitors are capable of diagnosing sporadic symptoms, and they offer faster and convenient monitoring. However, the mobile cardiac telemetry segment is expected to register the highest CAGR in the arrythmia monitoring devices market during 2021–2028.

Abbott, Koninklijke Philips N.V., General Electric Company, Hill-Rom Holding Inc., Medtronic, Biotronik, Inc., AliveCor, Inc, ACS Diagnostics, Medicalgorithmics, and OSI Systems, Inc are among the leading companies operating in the arrythmia monitoring devices market.

Market Insights

Increase in Incidence of Cardiovascular Diseases Fuels Arrythmia Monitoring Devices Market Growth
The world has witnessed notable developments in arrythmia monitoring devices in the last decade, offering physicians and patients new approaches to manage many diseases, including atrial arrhythmias, ventricular arrhythmias, and ventricular atrial fibrillation. The growing prevalence of arrhythmia and other cardiovascular diseases (CVDs) such as bradycardia, tachycardia, atrial fibrillation, ventricular fibrillation, and premature contraction is encouraging the introduction of improved diagnostic methods. Cardiac monitoring systems are simpler and quicker tools used for detecting arrhythmias, which has added to their popularity. According to the World Health Organization (WHO), CVDs are among the leading causes of death worldwide, and ~30 million people experience a stroke each year. According to the American Heart Association, almost half of all adults in the US have a type of CVD. Furthermore, more than 130 million people, i.e., 45.1%, of the US population, are projected to have a type of CVD by 2035. Further, lifestyle changes lead to the rise in the incidence of diseases such as diabetes, hypertension, dyslipidemia, and obesity, contributing to a surge in CVD cases across the world. Most types of CVDs can be prevented through pre-monitoring and pre-diagnosis. Likewise, arrhythmias, i.e., abnormalities in the heart functioning, can be averted with early diagnosis. The demand for arrhythmia monitoring devices is increasing as these devices can help save patients that are at a high risk of cardiac arrest.

The report segments arrythmia monitoring devices market as follows:

By Type

• ECG Monitors
• Implantable Monitors
• Holter Monitors
• Mobile Cardiac Telemetry
• Others

By Application

• Bradycardia
• Tachycardia
• Atrial Fibrillation
• Ventricular Fibrillation
• Premature Contraction
• Others

By End User

• Hospitals and Clinics
• Ambulatory Centers
• Diagnostic Centers
• Others

By Geography

• North America
 US
 Canada
 Mexico
• Europe
 France
 Germany
 UK
 Spain
 Italy
 Rest of Europe
• Asia Pacific (APAC)
 China
 India
 Japan
 Australia
 South Korea
 Rest of APAC
• Middle East and Africa (MEA)
 Saudi Arabia
 UAE
 South Africa
 Rest of MEA
• South and Central America (SCAM)
 Brazil
 Argentina
 Rest of SCAM

Purchase Copy of This Report at https://www.theinsightpartners.com/buy/TIPRE00004202/?openpr-10225

Contact Us
If you have any queries about this report or would like further information, please contact us:
North America: +1 646 491 9876
Asia-Pacific: +91 20 6727 8686
Email: sales@theinsightpartners.com

About The Insight Partners

The Insight Partners is a one-stop industry research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are specialist in industries such as Healthcare, Media, and Telecommunication.

Our research model is very simple. We believe in client servicing and delivering the best quality to our customers. Through our research content, we are making sure that our customers get value for their money along with better quality data and analysis.

Our research content is majorly focused towards market trends in terms of market sizing, competitive landscaping, company analysis, regional or country analysis, etc. We provide a detailed break-up of segmentation in terms of geography, products, applications, end users, etc., which helps our clients to gain a deeper analytical understanding of various research topics.

This release was published on openPR.